Johnson & Johnson announced definitive agreement to acquire Cougar Biotechnology. The company will initiate a tender offer to buy all outstanding shares of Cougar Biotechnology at $43 per share. The Boards of both Johnson & Johnson and Cougar Biotechnology have approved the transaction. The deal is expected to close in the third quarter of 2009.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Building on the April 2025 announcement, Dow will take actions across its three operating segments to support European profitability, resulting in the closure of sites in Germany and the UK.
Compelling solutions through strategic partnerships
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
